GVOKE HYPOPEN

Drug Xeris Pharmaceuticals, Inc.
Total Payments
$1.5M
Transactions
43,834
Doctors
18,564
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2024 $650,492 18,675 10,183
2023 $874,863 25,159 12,667

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $923,093 43,157 60.5%
Consulting Fee $285,160 187 18.7%
Honoraria $220,223 149 14.4%
Travel and Lodging $58,282 283 3.8%
Education $38,597 58 2.5%

Top Doctors Receiving Payments for GVOKE HYPOPEN — Page 4

Doctor Specialty Location Total Records
, MD Endocrinology, Diabetes & Metabolism Oak Park, IL $583.32 8
, MD, FACE Endocrinology, Diabetes & Metabolism Columbus, OH $577.50 1
, MD Endocrinology, Diabetes & Metabolism Brooklyn, NY $572.50 29
, DO General Practice Brodheadsville, PA $570.26 42
, M.D Endocrinology, Diabetes & Metabolism Atlanta, GA $567.85 26
, APRN Nurse Practitioner Sabetha, KS $555.28 22
, CNP Nurse Practitioner Grand Rapids, MI $548.97 27
, M.D Endocrinology, Diabetes & Metabolism Las Vegas, NV $542.37 23
, MD Endocrinology, Diabetes & Metabolism Brooklyn, NY $538.97 21
, PA Medical Irvine, CA $525.00 1
, D.O Endocrinology, Diabetes & Metabolism Bethpage, NY $523.82 20
, CNP Gerontology Cincinnati, OH $522.05 5
, MD Endocrinology, Diabetes & Metabolism Columbus, OH $508.03 20
, DNP, FNP-BC Nurse Practitioner Oak Brook, IL $505.25 13
, MD, FACE Endocrinology, Diabetes & Metabolism Gulfport, MS $503.46 26
, FNP-C Family Gulfport, MS $503.03 23
, MD Internal Medicine New York, NY $494.84 8
, M.D Internal Medicine Flushing, NY $493.99 4
, MD Endocrinology, Diabetes & Metabolism Cleveland, OH $489.08 11
, M.D Endocrinology, Diabetes & Metabolism Whitehall, PA $487.27 43
Elizabeth Devader Nurse Practitioner Topeka, KS $485.73 14
Adrienne Anderson Medical Atlanta, GA $483.14 17
, P.A Physician Assistant Grand Rapids, MI $469.55 18
, MD Nephrology Steubenville, OH $466.89 35
, D.O,MBA,MS,MT(ASCP) Internal Medicine Chicago, IL $461.29 14

About GVOKE HYPOPEN

GVOKE HYPOPEN is a drug associated with $1.5M in payments to 18,564 healthcare providers, recorded across 43,834 transactions in the CMS Open Payments database. The primary manufacturer is Xeris Pharmaceuticals, Inc..

Payment data is available from 2023 to 2024. In 2024, $650,492 was paid across 18,675 transactions to 10,183 doctors.

The most common payment nature for GVOKE HYPOPEN is "Food and Beverage" ($923,093, 60.5% of total).